|
Feb 18
|
|
$1.94
$1.94
+0.0%
|
SHORT
|
Benzinga
|
Geron Corp's RSI is 82.8, indicating a technically overbought condition. The stock has rallied significantly, gaining around 38% over the past month. Such a rapid and steep price increase, confirmed by the high RSI, makes the stock susceptible to a sharp pullback as early investors lock in substantial gains. The article includes GERN in its list of stocks that could "collapse." The trade is a short position based on the expectation of a technical correction from an overbought state, driven by profit-taking. Positive FY26 guidance and the commercial growth story for its drug RYTELO® could continue to attract buyers, sustaining the upward trend. Small-cap biotech stocks are notoriously volatile and can defy technical indicators on further positive news. |
Finnhub - AZN
Top 3 Health Care Stocks That May Collapse Th...
|